The number of new cases among intravenous drug users is declining, which seems to confirm the effectiveness of programmes to provide sterile syringes and needles.
Pēc tam, kad komiteja regulu izskatīja atkārtoti 31. janvārī, polemiskie grozījumi ziņojumā vairs nav ietverti.